Patents by Inventor Alisa E. Koch

Alisa E. Koch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers of chronic pelvic pain syndrome
    Patent number: 7794949
    Abstract: The present invention provides biomarkers of chronic pelvic pain syndrome for use in diagnosis, drug screening, therapy monitoring, research and therapeutic applications. In particular, the present invention provides MCP-1 and MIP-1? as biomarkers of chronic pelvic pain syndrome.
    Type: Grant
    Filed: April 27, 2005
    Date of Patent: September 14, 2010
    Assignee: Northwestern University
    Inventors: Anthony J. Schaeffer, Alisa E. Koch
  • Therapeutic methods that target fractalkine or CX3CR1
    Publication number: 20020054875
    Abstract: The invention relates to antagonists of CX3C chemokine receptor 1 (CX3CR1) function, antagonists of fractalkine function and to therapeutic methods employing the antagonists. The invention also relates to a method for diagnosing rheumatoid arthritis.
    Type: Application
    Filed: February 20, 2001
    Publication date: May 9, 2002
    Applicant: Northwestern University
    Inventors: Alisa E. Koch, Jeffrey H. Ruth, James B. Rottman
  • Therapeutic methods that target fractalkine or CX3CR1
    Publication number: 20020055456
    Abstract: The invention relates to antagonists of CX3C chemokine receptor 1 (CX3CR1) function, antagonists of fractalkine function and to therapeutic methods employing the antagonists. The invention also relates to a method for diagnosing rheumatoid arthritis.
    Type: Application
    Filed: February 20, 2001
    Publication date: May 9, 2002
    Applicant: Northwestern University
    Inventor: Alisa E. Koch
  • Murine hybridoma 4A11 and diagnostic antibody produced thereby
    Patent number: 5604126
    Abstract: Hybridoma 4A11 produces a murine IgM monoclonal antibody specifically against endothelial cells in diseased tissues such as rheumatoid and osteoarthritis synovial tissues, and psoriatic skin. The 4A11 antibody has possible clinical utility for detection of human endothelial cells mainly in inflamed and malignant disease states.
    Type: Grant
    Filed: May 26, 1995
    Date of Patent: February 18, 1997
    Assignee: Northwestern University
    Inventor: Alisa E. Koch